Frontiers in Cardiovascular Medicine (May 2022)
Different Effects on Protein Expression of CDR132L, an Antisense Inhibitor of miR-132, and Standard Therapies for Myocardial Infarction
Abstract
No abstracts available.Keywords
Frontiers in Cardiovascular Medicine (May 2022)